Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

In Vivo Multimodal Optical Imaging: Improved Detection of Oral Dysplasia in Low-Risk Oral Mucosal Lesions.

Yang EC, Schwarz RA, Lang AK, Bass N, Badaoui H, Vohra IS, Cherry KD, Williams MD, Gillenwater AM, Vigneswaran N, Richards-Kortum RR.

Cancer Prev Res (Phila). 2018 Aug;11(8):465-476. doi: 10.1158/1940-6207.CAPR-18-0032. Epub 2018 Jun 14.

PMID:
29903741
2.

Securing the Airway in Pretracheal Dermal Metastases From Oropharyngeal Carcinoma: A Case Report.

Truong AT, Truong DT, Gillenwater AM, Soliz JM, Rahlfs TF.

A A Pract. 2018 Apr 23. doi: 10.1213/XAA.0000000000000787. [Epub ahead of print]

PMID:
29688927
3.

Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions.

Yang EC, Tan MT, Schwarz RA, Richards-Kortum RR, Gillenwater AM, Vigneswaran N.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):670-681. doi: 10.1016/j.oooo.2018.02.020. Epub 2018 Mar 9. Review.

4.

Risk Stratification of Oral Potentially Malignant Disorders in Fanconi Anemia Patients Using Autofluorescence Imaging and Cytology-On-A Chip Assay.

Abram TJ, Pickering CR, Lang AK, Bass NE, Raja R, Meena C, Alousi AM, Myers JN, McDevitt JT, Gillenwater AM, Vigneswaran N.

Transl Oncol. 2018 Apr;11(2):477-486. doi: 10.1016/j.tranon.2018.01.014. Epub 2018 Feb 24.

5.

Rare presentation of heterotopic ossification along a fibula free flap pedicle in a high-volume microvascular reconstruction practice.

Mays AC, Gillenwater AM, Garvey PB.

Head Neck. 2018 Mar;40(3):E21-E24. doi: 10.1002/hed.25039. Epub 2017 Dec 22.

PMID:
29272061
6.

Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy.

Quinlan-Davidson SR, Mohamed ASR, Myers JN, Gunn GB, Johnson FM, Skinner H, Beadle BM, Gillenwater AM, Phan J, Frank SJ, William WN, Wong AJ, Lai SY, Fuller CD, Morrison WH, Rosenthal DI, Garden AS.

Oral Oncol. 2017 Sep;72:90-97. doi: 10.1016/j.oraloncology.2017.07.002. Epub 2017 Jul 16.

7.

Prospective Evaluation of Multimodal Optical Imaging with Automated Image Analysis to Detect Oral Neoplasia In Vivo.

Quang T, Tran EQ, Schwarz RA, Williams MD, Vigneswaran N, Gillenwater AM, Richards-Kortum R.

Cancer Prev Res (Phila). 2017 Oct;10(10):563-570. doi: 10.1158/1940-6207.CAPR-17-0054. Epub 2017 Aug 1.

PMID:
28765195
8.

Development of a multimodal foveated endomicroscope for the detection of oral cancer.

Shadfan A, Darwiche H, Blanco J, Gillenwater A, Richards-Kortum R, Tkaczyk TS.

Biomed Opt Express. 2017 Feb 14;8(3):1525-1535. doi: 10.1364/BOE.8.001525. eCollection 2017 Mar 1.

9.

Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy.

Quinlan-Davidson SR, Morrison WH, Myers JN, Gunn GB, William WN Jr, Beadle BM, Skinner HD, Gillenwater AM, Frank SJ, Phan J, Johnson FM, Fuller CD, Zafereo ME, Rosenthal DI, Garden AS.

Head Neck. 2017 Apr;39(4):633-638. doi: 10.1002/hed.24666. Epub 2016 Dec 22.

PMID:
28006086
10.

Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles.

Lukianova-Hleb EY, Kim YS, Belatsarkouski I, Gillenwater AM, O'Neill BE, Lapotko DO.

Nat Nanotechnol. 2016 Jun;11(6):525-32. doi: 10.1038/nnano.2015.343. Epub 2016 Feb 15.

PMID:
26878142
11.

Depression and Oropharynx Cancer Outcome.

Shinn EH, Valentine A, Jethanandani A, Basen-Engquist K, Fellman B, Urbauer D, Atkinson E, Yusuf SW, Lenihan D, Woods ML, Kies MS, Sood AK, Carmack C, Morrison WH, Gillenwater A, Sturgis EM, Garden AS.

Psychosom Med. 2016 Jan;78(1):38-48. doi: 10.1097/PSY.0000000000000256.

12.

Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.

William WN Jr, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM.

JAMA Oncol. 2016 Feb;2(2):209-16. doi: 10.1001/jamaoncol.2015.4364.

13.

Automated frame selection process for high-resolution microendoscopy.

Ishijima A, Schwarz RA, Shin D, Mondrik S, Vigneswaran N, Gillenwater AM, Anandasabapathy S, Richards-Kortum R.

J Biomed Opt. 2015 Apr;20(4):46014. doi: 10.1117/1.JBO.20.4.046014.

14.

Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.

Floriano PN, Abram T, Taylor L, Le C, Talavera H, Nguyen M, Raja R, Gillenwater A, McDevitt J, Vigneswaran N.

Oral Dis. 2015 Jul;21(5):593-601. doi: 10.1111/odi.12321. Epub 2015 Apr 6.

15.

Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy.

Bishop AJ, Garden AS, Gunn GB, Rosenthal DI, Beadle BM, Fuller CD, Levy LB, Gillenwater AM, Kies MS, Esmaeli B, Frank SJ, Phan J, Morrison WH.

Head Neck. 2016 Apr;38 Suppl 1:E452-8. doi: 10.1002/hed.24017. Epub 2015 Jul 14.

PMID:
25645649
16.

Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer.

Kawedia JD, Zhang YP, Myers AL, Richards-Kortum RR, Kramer MA, Gillenwater AM, Culotta KS.

J Oncol Pharm Pract. 2016 Feb;22(1):21-5. doi: 10.1177/1078155214546564. Epub 2014 Aug 10.

PMID:
25113309
17.

Vital-dye-enhanced multimodal imaging of neoplastic progression in a mouse model of oral carcinogenesis.

Hellebust A, Rosbach K, Wu JK, Nguyen J, Gillenwater A, Vigneswaran N, Richards-Kortum R.

J Biomed Opt. 2013 Dec;18(12):126017. doi: 10.1117/1.JBO.18.12.126017.

18.

Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics.

Gillenwater AM, Vigneswaran N, Fatani H, Saintigny P, El-Naggar AK.

Head Neck. 2014 Nov;36(11):1662-8. doi: 10.1002/hed.23505. Epub 2014 Aug 28. Review.

PMID:
24115154
19.

Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!

Gillenwater AM, Vigneswaran N, Fatani H, Saintigny P, El-Naggar AK.

Adv Anat Pathol. 2013 Nov;20(6):416-23. doi: 10.1097/PAP.0b013e3182a92df1. Review.

PMID:
24113312
20.

Multimodal snapshot spectral imaging for oral cancer diagnostics: a pilot study.

Bedard N, Schwarz RA, Hu A, Bhattar V, Howe J, Williams MD, Gillenwater AM, Richards-Kortum R, Tkaczyk TS.

Biomed Opt Express. 2013 May 24;4(6):938-49. doi: 10.1364/BOE.4.000938. Print 2013 Jun 1.

21.

Primary intestinal-like adenocarcinoma of major salivary glands: 2 instances of previously undocumented phenotype.

Gillenwater AM, Frank SJ, Fatani H, El-Naggar AK.

Head Neck. 2013 Aug;35(8):E234-6. doi: 10.1002/hed.23059. Epub 2012 Oct 29.

PMID:
23108630
22.

Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa.

Rosbach KJ, Williams MD, Gillenwater AM, Richards-Kortum RR.

Transl Oncol. 2012 Jun;5(3):160-71. Epub 2012 Jun 1.

23.

Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia.

Pierce MC, Schwarz RA, Bhattar VS, Mondrik S, Williams MD, Lee JJ, Richards-Kortum R, Gillenwater AM.

Cancer Prev Res (Phila). 2012 Jun;5(6):801-9. doi: 10.1158/1940-6207.CAPR-11-0555. Epub 2012 May 2.

24.

Discrimination of benign and neoplastic mucosa with a high-resolution microendoscope (HRME) in head and neck cancer.

Vila PM, Park CW, Pierce MC, Goldstein GH, Levy L, Gurudutt VV, Polydorides AD, Godbold JH, Teng MS, Genden EM, Miles BA, Anandasabapathy S, Gillenwater AM, Richards-Kortum R, Sikora AG.

Ann Surg Oncol. 2012 Oct;19(11):3534-9. doi: 10.1245/s10434-012-2351-1. Epub 2012 Apr 11.

25.

High-Resolution Optical Imaging of Benign and Malignant Mucosa in the Upper Aerodigestive Tract: An Atlas for Image-Guided Surgery.

Levy LL, Vila PM, Park RW, Schwarz R, Polydorides AD, Teng MS, Gurudutt VV, Genden EM, Miles B, Anandasabapathy S, Gillenwater AM, Richards-Kortum R, Sikora AG.

ISRN Minim Invasive Surg. 2012;2012. pii: 364285.

26.

The future of medical diagnostics: review paper.

Jerjes WK, Upile T, Wong BJ, Betz CS, Sterenborg HJ, Witjes MJ, Berg K, van Veen R, Biel MA, El-Naggar AK, Mosse CA, Olivo M, Richards-Kortum R, Robinson DJ, Rosen J, Yodh AG, Kendall C, Ilgner JF, Amelink A, Bagnato V, Barr H, Bolotine L, Bigio I, Chen Z, Choo-Smith LP, D'Cruz AK, Gillenwater A, Leunig A, MacRobert AJ, McKenzie G, Sandison A, Soo KC, Stepp H, Stone N, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Hopper C.

Head Neck Oncol. 2011 Aug 23;3:38. doi: 10.1186/1758-3284-3-38.

27.

Noninvasive imaging of oral neoplasia with a high-resolution fiber-optic microendoscope.

Muldoon TJ, Roblyer D, Williams MD, Stepanek VM, Richards-Kortum R, Gillenwater AM.

Head Neck. 2012 Mar;34(3):305-12. doi: 10.1002/hed.21735. Epub 2011 Mar 16.

28.

Prospective evaluation of a portable depth-sensitive optical spectroscopy device to identify oral neoplasia.

Schwarz RA, Gao W, Stepanek VM, Le TT, Bhattar VS, Williams MD, Wu JK, Vigneswaran N, Adler-Storthz K, Gillenwater AM, Richards-Kortum R.

Biomed Opt Express. 2010 Dec 8;2(1):89-99. doi: 10.1364/BOE.2.000089.

29.

At the frontiers of surgery: review.

Upile T, Jerjes WK, Sterenborg HJ, Wong BJ, El-Naggar AK, Ilgner JF, Sandison A, Witjes MJ, Biel MA, van Veen R, Hamdoon Z, Gillenwater A, Mosse CA, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Barr H, Chen Z, Berg K, D'Cruz AK, Sudhoff H, Stone N, Kendall C, Fisher S, MacRobert AJ, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Bigio I, Yodh AG, Hopper C.

Head Neck Oncol. 2011 Feb 9;3(1):7. doi: 10.1186/1758-3284-3-7.

30.

Ex vivo high resolution imaging with a miniaturized microendoscope to discriminate between benign and malignant mucosa in the upper aerodigestive tract.

Levy L, Smith C, Gurudutt V, Teng M, Rivera M, Anadasabapathy S, Genden E, Gillenwater A, Richards-Kortum R, Sikora A.

Laryngoscope. 2010;120 Suppl 4:S162. doi: 10.1002/lary.21626. No abstract available.

PMID:
21225760
31.

Comparison of multispectral wide-field optical imaging modalities to maximize image contrast for objective discrimination of oral neoplasia.

Roblyer D, Kurachi C, Stepanek V, Schwarz RA, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R.

J Biomed Opt. 2010 Nov-Dec;15(6):066017. doi: 10.1117/1.3516593.

32.

Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.

Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS.

Ann Intern Med. 2010 Sep 21;153(6):358-67. doi: 10.7326/0003-4819-153-6-201009210-00003.

PMID:
20855800
33.

Advances in fluorescence imaging techniques to detect oral cancer and its precursors.

Shin D, Vigneswaran N, Gillenwater A, Richards-Kortum R.

Future Oncol. 2010 Jul;6(7):1143-54. doi: 10.2217/fon.10.79. Review.

34.

A fiber-optic fluorescence microscope using a consumer-grade digital camera for in vivo cellular imaging.

Shin D, Pierce MC, Gillenwater AM, Williams MD, Richards-Kortum RR.

PLoS One. 2010 Jun 23;5(6):e11218. doi: 10.1371/journal.pone.0011218.

35.

Evaluation of a low-cost, portable imaging system for early detection of oral cancer.

Rahman MS, Ingole N, Roblyer D, Stepanek V, Richards-Kortum R, Gillenwater A, Shastri S, Chaturvedi P.

Head Neck Oncol. 2010 Apr 22;2:10. doi: 10.1186/1758-3284-2-10.

36.

Emerging roles for multimodal optical imaging in early cancer detection: a global challenge.

Bedard N, Pierce M, El-Nagger A, Anandasabapathy S, Gillenwater A, Richards-Kortum R.

Technol Cancer Res Treat. 2010 Apr;9(2):211-7. Review.

37.

Efficient mucosal delivery of optical contrast agents using imidazole-modified chitosan.

Ghosn B, van de Ven AL, Tam J, Gillenwater A, Sokolov KV, Richards-Kortum R, Roy K.

J Biomed Opt. 2010 Jan-Feb;15(1):015003. doi: 10.1117/1.3309739.

38.

Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics.

Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, Amos CI, Guo Z, Qiao Y, Gillenwater AM, Myers JN, Clayman GL, Weber RS, El-Naggar AK, Mao L, Lippman SM, Hong WK, Wei Q.

Clin Cancer Res. 2010 Jan 15;16(2):764-74. doi: 10.1158/1078-0432.CCR-09-2156. Epub 2010 Jan 12.

39.

Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, Sagesaka YM, Hong WK, Papadimitrakopoulou V.

Cancer Prev Res (Phila). 2009 Nov;2(11):931-41. doi: 10.1158/1940-6207.CAPR-09-0121.

40.

Incidental detection of an occult oral malignancy with autofluorescence imaging: a case report.

Vigneswaran N, Koh S, Gillenwater A.

Head Neck Oncol. 2009 Oct 28;1:37. doi: 10.1186/1758-3284-1-37.

41.

Ecthyma gangrenosum: an unusual cutaneous manifestation of the head and neck.

Funk E, Ivan D, Gillenwater AM.

Arch Otolaryngol Head Neck Surg. 2009 Aug;135(8):818-20. doi: 10.1001/archoto.2009.93.

PMID:
19687405
42.

Multidimensional analysis of body image concerns among newly diagnosed patients with oral cavity cancer.

Fingeret MC, Vidrine DJ, Reece GP, Gillenwater AM, Gritz ER.

Head Neck. 2010 Mar;32(3):301-9. doi: 10.1002/hed.21181.

43.

Head & neck optical diagnostics: vision of the future of surgery.

Upile T, Jerjes W, Sterenborg HJ, El-Naggar AK, Sandison A, Witjes MJ, Biel MA, Bigio I, Wong BJ, Gillenwater A, MacRobert AJ, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Mosse CA, Barr H, Chen Z, Berg K, D'Cruz AK, Stone N, Kendall C, Fisher S, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Yodh AG, Hopper C.

Head Neck Oncol. 2009 Jul 13;1:25. doi: 10.1186/1758-3284-1-25.

44.

Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia.

Nitin N, Rosbach KJ, El-Naggar A, Williams M, Gillenwater A, Richards-Kortum RR.

Neoplasia. 2009 Jun;11(6):542-51.

45.

Objective detection and delineation of oral neoplasia using autofluorescence imaging.

Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R.

Cancer Prev Res (Phila). 2009 May;2(5):423-31. doi: 10.1158/1940-6207.CAPR-08-0229. Epub 2009 Apr 28.

46.

Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.

Holsinger FC, Kies MS, Diaz EM Jr, Gillenwater AM, Lewin JS, Ginsberg LE, Glisson BS, Garden AS, Ark N, Lin HY, Lee JJ, El-Naggar AK, Ki Hong W, Shin DM, Khuri FR.

J Clin Oncol. 2009 Apr 20;27(12):1976-82. doi: 10.1200/JCO.2008.17.6396. Epub 2009 Mar 16.

47.

Fluorescence spectroscopy of oral tissue: Monte Carlo modeling with site-specific tissue properties.

Pavlova I, Weber CR, Schwarz RA, Williams MD, Gillenwater AM, Richards-Kortum R.

J Biomed Opt. 2009 Jan-Feb;14(1):014009. doi: 10.1117/1.3065544.

48.

Molecular imaging of glucose uptake in oral neoplasia following topical application of fluorescently labeled deoxy-glucose.

Nitin N, Carlson AL, Muldoon T, El-Naggar AK, Gillenwater A, Richards-Kortum R.

Int J Cancer. 2009 Jun 1;124(11):2634-42. doi: 10.1002/ijc.24222.

49.

Noninvasive evaluation of oral lesions using depth-sensitive optical spectroscopy.

Schwarz RA, Gao W, Redden Weber C, Kurachi C, Lee JJ, El-Naggar AK, Richards-Kortum R, Gillenwater AM.

Cancer. 2009 Apr 15;115(8):1669-79. doi: 10.1002/cncr.24177.

50.

Cyclin D1 and cancer development in laryngeal premalignancy patients.

Papadimitrakopoulou V, Izzo JG, Liu DD, Myers J, Ceron TL, Lewin J, William WN Jr, Atwell A, Lee JJ, Gillenwater A, El-Naggar A, Wu X, Lippman SM, Hittelman WN, Hong WK.

Cancer Prev Res (Phila). 2009 Jan;2(1):14-21. doi: 10.1158/1940-6207.CAPR-08-0111.

Supplemental Content

Loading ...
Support Center